Michael Conley
Family · Ontario, CANPI 1952647638
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 214 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 33.5% of the total. 2025 is the largest year on record at $1,649, more than ten times the $15 reported in 2021. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 214 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$549
- Otsuka America Pharmaceutical, Inc.$526
- Johnson & Johnson$358
- Alkermes, Inc.$235
- Lundbeck LLC$195
- plus $900 from 10 others
What the payments were for
- Food & beverage$4,152100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 60 | $1,390 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 37 | $549 |
| Otsuka America Pharmaceutical, Inc. | 30 | $526 |
| Johnson & Johnson(2 entities) | 15 | $358 |
| Alkermes, Inc. | 9 | $235 |
| Lundbeck LLC | 11 | $195 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $181 |
| Neurocrine Biosciences, Inc. | 10 | $181 |
| Axsome Therapeutics, Inc. | 6 | $115 |
| Corium, LLC | 8 | $110 |
| Vanda Pharmaceuticals Inc. | 6 | $92 |
| Teva Pharmaceuticals USA, Inc. | 4 | $82 |
| Collegium Pharmaceutical, Inc. | 4 | $80 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Olympus America Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$118
How this compares
$4,152 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 27 | $1,155 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 42 | $815 |
| Alprazolam | 40 | $338 |
| Bupropion XlBupropion Hcl | 18 | $266 |
| Lithium Carbonate ErLithium Carbonate | 13 | $240 |
| Clonazepam | 24 | $236 |
| Lorazepam | 18 | $215 |
| Gabapentin | 22 | $197 |
| Diazepam | 14 | $153 |
| Hydroxyzine Hcl | 12 | $129 |
| Baclofen | 11 | $129 |
| Aripiprazole | 11 | $128 |
| Quetiapine Fumarate | 15 | $81 |
Paid to pharmacies, not to this prescriber.
Other family in Ontario
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.